glp-1 degradation Profiles. Shown are the profiles of native (), (Pro 9 Recent updates on GLP-1 agonists:

BID, Two times a day

The Impact of GLP-1 on Bone Quality Glucagon-like peptide-1 may improve bone quality

Following a thorough analysis of our previous Phase IIb data and trial design, we are confident that with the preferred modified release formulation and optimized future trial design, we can advance a competitive oral GLP-1 molecule into registration-enabling studies to meet the ongoing medical needs of people living with obesity. The ongoing open-label, randomized study is assessing the pharmacokinetics and safety of immediate- and modified-release formulations of danuglipron administered orally in healthy adults aged 18 years or older

Of the two peptides only OXM was found to stimulate insulin secretion but its potency was too low to be of clinical benefit (Holst 2024

However, the reason behind the loss of these dopamine-producing nerve cells remains unclear (57)